{"id":"W4200113990","doi":"10.1016/j.drup.2021.100794","title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","year":2021,"lang":"en","type":"review","venue":"Drug Resistance Updates","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"ca_institutions":"CancerCare Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Silesian University of Technology","keywords":"Medicine; Hydroxychloroquine; Pandemic; Lopinavir; Coronavirus disease 2019 (COVID-19); Ribavirin; Intensive care medicine; Ritonavir; Interim analysis; Clinical endpoint; Randomized controlled trial; Interim; Disease; Internal medicine; Viral load; Virology; Virus; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008883828,0.001143461,0.004027178,0.0003737506,0.0004619413,0.0001792887,0.0006012281,0.0003328297,0.00009750039],"category_scores_gemma":[0.002416648,0.0007173044,0.001279411,0.0006887084,0.0004635231,0.0001189094,0.0001201943,0.0006345221,0.0001066383],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001697894,"about_ca_system_score_gemma":0.003916149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006787918,"about_ca_topic_score_gemma":0.0002933538,"domain_scores_codex":[0.9942971,0.0005523588,0.001106826,0.001932024,0.001038641,0.001072984],"domain_scores_gemma":[0.9917403,0.004754325,0.0005318614,0.002017793,0.0003811745,0.000574471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003423296,0.002478233,0.00001281262,0.0631431,0.005517912,0.00115249,0.0003991605,0.0000168861,0.00002055902,0.002342797,0.02316328,0.8983294],"study_design_scores_gemma":[0.002598856,0.0008441064,0.000002613739,0.008337136,0.003311886,0.00000554406,0.00008659492,0.00002113741,0.0001034771,0.0003095644,0.9836964,0.0006826796],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004221933,0.9855965,0.0006398534,0.008150595,0.0001767451,0.004227161,0.0007550411,0.0002296725,0.0001821669],"genre_scores_gemma":[0.000283118,0.9839632,0.001149051,0.00593786,0.0005590876,0.001929115,0.002054855,0.0002292635,0.003894477],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9605331,"threshold_uncertainty_score":0.9995278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.113283966716191,"score_gpt":0.4875776992917716,"score_spread":0.3742937325755806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}